Bornaprine: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
| verifiedrevid = 444149363 | | verifiedrevid = 444149363 | ||
| IUPAC_name = 3-diethylaminopropyl 6-cyclohexylbicyclo[2.2.1]heptane-6-carboxylate | | IUPAC_name = 3-diethylaminopropyl 6-cyclohexylbicyclo[2.2.1]heptane-6-carboxylate | ||
| image = Bornaprine. | | image = Bornaprine.png | ||
<!--Clinical data--> | <!--Clinical data--> | ||
Line 44: | Line 44: | ||
| StdInChIKey = BDNMABJZSXTKAQ-UHFFFAOYSA-N | | StdInChIKey = BDNMABJZSXTKAQ-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Bornaprine''' is an [[anticholinergic]] used as an [[antiparkinsonian]] agent.<ref>{{cite pmid|3514543}}</ref><ref>{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=62nd|isbn=978-3-85200-181-4|language=German}}</ref> | '''Bornaprine''' is an [[anticholinergic]] used as an [[antiparkinsonian]] agent.<ref>{{cite pmid|3514543}}</ref><ref>{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=62nd|isbn=978-3-85200-181-4|language=German}}</ref> | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist|2}} | ||
[[Category:Antiparkinsonian agents]] | [[Category:Antiparkinsonian agents]] | ||
Line 58: | Line 59: | ||
[[Category:Carboxylate esters]] | [[Category:Carboxylate esters]] | ||
[[Category:Amines]] | [[Category:Amines]] | ||
[[Category:Drug]] | |||
Latest revision as of 16:06, 9 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C21H31NO2 |
Molar mass | 329.476 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Bornaprine |
Articles |
---|
Most recent articles on Bornaprine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bornaprine at Clinical Trials.gov Clinical Trials on Bornaprine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bornaprine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bornaprine Discussion groups on Bornaprine Patient Handouts on Bornaprine Directions to Hospitals Treating Bornaprine Risk calculators and risk factors for Bornaprine
|
Healthcare Provider Resources |
Causes & Risk Factors for Bornaprine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bornaprine is an anticholinergic used as an antiparkinsonian agent.[1][2]
References
- ↑ PMID 3514543 (PMID 3514543)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ Jasek, W, ed. (2007). Austria-Codex (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
- Pages with script errors
- Pages with incomplete PMID references
- CS1 maint: Unrecognized language
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Antiparkinsonian agents
- Muscarinic antagonists
- Carboxylate esters
- Amines
- Drug